This was also highlighted by Sadasivan et al., who found a higher risk of biochemical recurrence in patients whose prostate cancer biopsy was enriched for M2 macrophages and characterized by elevated GDF-15 expression [151]. The gene discussed is GDF15; the disease is prostate cancer.